Stock Analysis on Net
Stock Analysis on Net

GlaxoSmithKline PLC (NYSE:GSK)

This company has been moved to the archive! The financial data has not been updated since February 27, 2015.

Common-Size Balance Sheet: Assets

GlaxoSmithKline PLC, common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Property, plant and equipment 22.27 21.08 21.16 21.30 21.42
Goodwill 9.16 9.99 10.51 9.14 8.54
Other intangible assets 20.47 22.06 24.50 18.99 20.20
Joint ventures 0.02 0.04 0.05 0.07 0.13
Associated 0.82 0.73 1.34 1.29 2.43
Investments in associates and joint ventures 0.84% 0.77% 1.40% 1.36% 2.56%
Other investments 2.74 2.86 1.90 1.44 1.68
Deferred tax assets 6.61 4.95 5.75 6.94 6.08
Derivative financial instruments 0.00 0.00 0.13 0.21 0.23
Amounts receivable under insurance contracts 1.10 0.94 0.87 0.82 0.81
Pension schemes in surplus 0.23 0.78 0.30 0.05 0.05
Other receivables 0.48 0.39 0.48 0.41 0.45
Other non-current assets 1.81% 2.11% 1.64% 1.28% 1.32%
Non-current assets 63.89% 63.82% 66.99% 60.65% 62.03%
Inventories 10.41 9.27 9.57 9.43 9.09
Current tax recoverable 0.34 0.31 0.25 0.21 0.13
Trade receivables, net of provision for bad and doubtful debts 8.75 9.42 9.92 10.81 11.19
Prepaid pension contributions 0.00 0.00 0.00 0.00 0.00
Other prepayments and accrued income 0.71 0.69 0.68 0.83 0.61
Interest receivable 0.02 0.02 0.03 0.02 0.04
Employee loans and advances 0.07 0.09 0.10 0.10 0.12
Other receivables 1.77 2.71 1.91 1.81 1.76
Trade and other receivables 11.32% 12.93% 12.64% 13.57% 13.72%
Derivative financial instruments 0.36 0.37 0.12 0.17 0.22
Liquid investments 0.17 0.16 0.20 0.45 0.44
Cash and cash equivalents 10.67 13.15 10.09 13.91 14.34
Assets held for sale 2.84 0.00 0.15 1.62 0.04
Current assets 36.11% 36.18% 33.01% 39.35% 37.97%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Balance sheet item Description The company
Property, plant and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. GlaxoSmithKline PLC property, plant and equipment as a percentage of total assets decreased from 2012 to 2013 but then increased from 2013 to 2014 exceeding 2012 level.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. GlaxoSmithKline PLC non-current assets as a percentage of total assets decreased from 2012 to 2013 but then slightly increased from 2013 to 2014.
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. GlaxoSmithKline PLC current assets as a percentage of total assets increased from 2012 to 2013 but then slightly decreased from 2013 to 2014.